Endava (DAVA) EBITDA (2017 - 2026)

Endava's EBITDA history runs 10 years deep, the most recent figure standing at -$30.3 million for Q1 2026.

• On a quarterly basis, EBITDA fell 808.09% year-over-year to -$30.3 million in Q1 2026; TTM through Mar 2026 was -$33.0 million, a 1442.63% decrease from a year earlier, with the FY2025 full-year figure at -$3.9 million, up 68.83% from the prior year.
• EBITDA fell to -$30.3 million in Q1 2026 per DAVA's latest filing, from $425653.2 in the prior quarter.
• Across five years, EBITDA topped out at $38.5 million in Q4 2022 and bottomed at -$30.3 million in Q1 2026.
• The 5-year median for EBITDA is $425653.2 (2025), against an average of $9.5 million.
• Across the five-year window, EBITDA soared 116.64% in 2025 and slumped 808.09% in 2026, its largest moves.
• Year by year, EBITDA stood at $38.5 million in 2022, then sank by 85.1% to $5.7 million in 2023, then fell by 2.66% to $5.6 million in 2024, then plunged by 92.37% to $425653.2 in 2025, then plunged by 7223.3% to -$30.3 million in 2026.
• Per Business Quant, the three latest DAVA EBITDA figures stand at -$30.3 million (Q1 2026), $425653.2 (Q4 2025), and $425049.1 (Q3 2025).